Income Tax - Schedule of Effective Income Tax Rate Reconciliation, Prior to Adoption of ASU 2023-09 (Details) - USD ($) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Amount | ||
| Federal statutory income tax | $ 2,867,000 | $ 2,281,000 |
| Tax-exempt interest | (672,000) | |
| Effect of state income taxes | (92,000) | |
| ESOP | 1,000 | (92,000) |
| Cash surrender value - life insurance | (20,000) | (19,000) |
| Low-income housing tax credit (net of amortization) | (30,000) | |
| Small insurance captive premiums | (165,000) | (183,000) |
| Stock compensation | (54,000) | 11,000 |
| Carryforward attribute expiration | 407,000 | |
| Other | (125,000) | |
| Total income tax expense | $ 2,076,261 | $ 1,486,348 |
| X | ||||||||||
- Definition Effective Income Tax Rate Reconciliation, Carryforward Attribute Expiration, Amount No definition available.
|
| X | ||||||||||
- Definition Represents the monetary amount of Cash surrender value - life insurance - tax, during the indicated time period. No definition available.
|
| X | ||||||||||
- Definition Effective Income Tax Rate Reconciliation, Nondeductible Expense, Employee Stock Ownership Plan, Amount No definition available.
|
| X | ||||||||||
- Definition Effective Income Tax Rate Reconciliation, Nondeductible Expense, Small Insurance Captive Premiums, Amount No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in state and local income tax contingency. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of operating interest income, including amortization and accretion of premiums and discounts, on securities exempt from state, federal and other income tax. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|